Showing results (2961-2970 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|July 12, 2014
Pharmacokinetics and safety of subcutaneous pasireotide and intramuscular pasireotide long-acting release in Chinese male healthy volunteers: a phase I, single-center, open-label, randomized studyXia Chen, Guoxiang Shen, Ji Jiang, et al.
Clinical Therapeutics|July 12, 2014
The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudicationHaeyeon Hong, William C Mackey
Clinical Therapeutics|July 12, 2014
Clinical and economic burden in patients with diagnosis of peripheral arterial disease in a claims database in JapanAkihiro Hosaka, Tetsuro Miyata, Yoshie Onishi, et al.
Clinical Therapeutics|October 5, 2013
Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladderMichael B Chancellor, Kristen Migliaccio-Walle, Thomas J Bramley, et al.
Clinical Therapeutics|October 8, 2013
Bioequivalence of two intravenous formulations of antithrombin III: a two-way crossover study in healthy Korean subjectsKyoung-Ah Kim, Yoon-Young Lim, Sun-Ho Kim, et al.
Clinical Therapeutics|October 8, 2013
Exposure-response (safety) analysis to identify linifanib dose for a Phase III study in patients with hepatocellular carcinomaYi-Lin Chiu, Dawn M Carlson, Rajendra S Pradhan, et al.
Clinical Therapeutics|October 19, 2013
Treatment satisfaction in renal transplant patients taking tacrolimus once dailyGerben A J van Boekel, Chantal H H Kerkhofs, Luuk B Hilbrands
Clinical Therapeutics|October 22, 2013
Current and emerging therapies for Alzheimer's diseaseHaakon B Nygaard
Clinical Therapeutics|October 22, 2013
Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteersSarah I Sheikh, Ivan Nestorov, Heidy Russell, et al.
Clinical Therapeutics|August 23, 2014
Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapySoon Yong Suh, Taehoon Ahn, Jang-Ho Bae, et al.
Pageof 680